Condition: Pancreatic Cancer · Microbiota · Cachexia · Sponsor: Genton Graf Laurence
This monocentric study aims at evaluating the effects of fecal microbiota transplantation from newly diagnosed cachectic and non-cachectic pancreatic cancer patients, and healthy volunteers on several cachexia-related parameters of germ-free mice.
This description comes directly from the study's public registry record.
Laurence Genton Graf, Prof · +41 22 3729344 · laurence.genton@hcuge.ch
Alexandra Hemmer, MSc · +41795530491 · alexandra.hemmer@hcuge.ch
Always discuss trial participation with your own doctor first.
| Geneva University Hospitals | Geneva, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05606523